Incyte Announces the Validation by the European Medicines Agency of its Marketin
- This topic has 0 replies, 1 voice, and was last updated 4 years, 3 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Incyte Announces the Validation by the European Medicines Agency of its Marketing Authorization Application for Pemigatinib in Patients with Cholangiocarcinoma
Viewing 1 post (of 1 total)
- The forum ‘Chemotherapy & More’ is closed to new topics and replies.